Related Experiment Video
Updated: Aug 11, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
Characterization of a novel immunocytolytic factor secreted by pancreatic adenocarcinoma
C M Divino1, L P Angel, S T Brower
1Department of Surgery, Mount Sinai School of Medicine, The Mount Sinai Medical Center, New York, NY 10029-6574, USA.
Abstract:
We observed a putative immunocytolytic factor secreted in the supernatant of several pancreatic adenocarcinoma cell lines that induces apoptosis in lymphocytes. A marked reduction in the viability of the target splenocytes was evident after coincubation with the supernatants from various pancreatic adenocarcinoma cell lines (human, hamster, and murine). The immunocytolytic effect was not evident with the conditioned media of normal pancreatic duct epithelial cells or other nonpancreatic tumor cells. Biologic activity of the supernatants was determined to be heat sensitive and reside in a 30- to 50-kDa range. Immune and functional assays have excluded known immunosuppressive factors.

